Trending News
News
News
Common Drug Shows Potential as Alzheimer's Cure
A research project has shown that an experimental model of Alzheimer’s disease can be successfully treated with a commonly used anti-inflammatory drug.
News
Characterizing the Mouse Gut Microbiome
Study establishes the first public collection of bacteria from the intestine of mice.
News
Schizophrenia, Autism Share Genetic Causes
Monkey brain developmental atlas pinpoints when, where genes activate.
News
Tobacco Hornworm Genome Sequenced
A Kansas State University-led international team has sequenced the genome of the tobacco hornworm — a caterpillar species used in many research laboratories for studies of insect biology.
News
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
News
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
News
Esteve Gains Sample Management Efficiencies Using Titian’s Software
The Mosaic software has been extended to support the whole of sample management research at Esteve’s R&D site.
News
How Parkinson’s Disease Alters Brain Activity Over Time
The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
News
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
News
How Parkinson's disease alters brain activity over time
Neuroscientists peered into the brains of patients with Parkinson's disease and two similar conditions to see how their neural responses changed over time. The study, funded by the National Institutes of Health's (NIH's, USA) Parkinson's Disease Biomarkers Program and published in Neurology, may provide a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
Advertisement